Logo

Sophia Genetics: Peter Casasanto, Abhi Verma

Jan 10, 2022

Sophia Genetics has hired Peter Casasanto as chief biopharma officer and Abhimanyu (Abhi) Verma as chief technology officer. Casasanto, who has more than 15 years of experience in life sciences business development and sales, comes to Sophia after serving as VP of new commercialization initiatives for Canadian precision medicine laboratory services provider CellCarta. Verma previously had several leadership positions at Novartis, covering applied technology innovation, real-world evidence, drug development, enterprise technologies, IT strategy, data science, and artificial intelligence.

Breaking News
The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.